TurboGen Reports First Half 2026 Financial Results and Advances Commercialization Preparations
TurboGen reported first half 2026 results with zero revenue, as the company remains in development stage ahead of first microturbine installations expected toward the end of 2026. Operating loss widened to $5.2 million from $2.3 million on higher R&D and Nasdaq-listing costs, though net loss narrowed 45% to $4.2 million on a $6.4 million favorable warrant fair-value change.
Key figures
- Eps
- 0
- Revenue
- 0
- Net loss
- 4200000
- Ga expense
- 3100000
- Rd expense
- 1900000
- Operating loss
- 5200000
- Operating cash use
- 2700000
- Net loss prior year
- 7600000
- Shareholders equity
- 1600000
- Cash and equivalents
- 7200000
- Sales marketing expense
- 281000
- Private placement gross proceeds
- 5000000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.